ANXA1 and cancer: We previously demonstrated that both non-steroidal and steroidal anti-inflammatory drugs such as glucocorticoids and nitric oxide–aspirin, induce expression of ANXA1, which directly binds to the NF-κB p65 subunit, and thereby inhibits its activation in cancer models (26).